ASCEND BY NTHRYS
Research Abroad Products

Biostatistics Project Topics

Browse all focused areas across all project categories under this field.

Showing 49–60 of 200 project topics
Epigenomics DNA Methylation and Histone Modification Analysis Service
Commercial platform analyzing WGBS and ChIP-seq data to quantify methylation patterns, identify regulatory regions, and predict gene silencing for cancer and developmental biology research. Generates revenue through per-sample processing, data storage, and white-label licensing to research institutions.
Genomics & Omics Biostatistics Analytics Services Click to view more details →
Integrated Multi-Omics Data Fusion and Machine Learning Modeling Suite
Advanced SaaS platform integrating genomics, proteomics, metabolomics, and clinical data with supervised and unsupervised ML models for biomarker discovery and patient stratification. Captures market value through enterprise licensing, pharmaceutical partnerships, and precision medicine diagnostic reports.
Genomics & Omics Biostatistics Analytics Services Click to view more details →
Real-World Data Integration Platform for Clinical Evidence
A SaaS platform that aggregates and harmonizes disparate RWD sources including EHRs, claims, registries, and wearables into standardized datasets for biostatistical analysis. This enables pharmaceutical and medical device companies to generate real-world evidence submissions for regulatory approval and pricing negotiations, reducing time-to-market by 40-60%.
Real-World Evidence Biostatistics Platform Dev Click to view more details →
Regulatory-Grade RWE Statistical Analysis and Reporting Tool
A specialized biostatistics software that performs FDA-compliant analysis of real-world evidence with automated statistical validation, bias adjustment, and audit trails for regulatory submissions. This reduces statistical review cycles and enables companies to capture premium pricing strategies based on robust RWE evidence, directly impacting market exclusivity claims.
Real-World Evidence Biostatistics Platform Dev Click to view more details →
Patient-Level Data Matching Engine for Comparative Effectiveness
A proprietary algorithm platform that performs sophisticated propensity score matching and covariate balancing across heterogeneous RWD cohorts to enable valid comparative effectiveness research without randomization. This delivers high-confidence comparative evidence for payers and clinicians, supporting market access negotiations and formulary positioning worth millions in annual revenue.
Real-World Evidence Biostatistics Platform Dev Click to view more details →
Real-World Evidence Data Quality Assurance Analytics Suite
An automated biostatistics platform that identifies data completeness gaps, outliers, and quality issues across real-world datasets with machine learning-driven anomaly detection and corrective workflows. This ensures data integrity for regulatory submissions and reduces costly data cleaning cycles by 70%, enabling faster market-ready evidence generation.
Real-World Evidence Biostatistics Platform Dev Click to view more details →
Adaptive Trial Design and Analysis Platform for RWD Studies
A cloud-based biostatistics tool that enables dynamic sample size re-estimation, interim analysis, and adaptive enrollment strategies specifically designed for real-world evidence collection protocols. This accelerates study completion and reduces operational costs by 30-50% while maintaining statistical rigor, creating significant competitive advantage in evidence generation timelines.
Real-World Evidence Biostatistics Platform Dev Click to view more details →
Machine Learning-Enhanced Causal Inference for RWE Analytics
An advanced biostatistics platform leveraging machine learning for confounding adjustment, heterogeneous treatment effect estimation, and causal impact modeling from observational real-world data. This generates clinically credible causal claims that compete with RCT evidence, enabling companies to support premium pricing and expanded indications without new trials.
Real-World Evidence Biostatistics Platform Dev Click to view more details →
Real-World Evidence Outcomes Registry Benchmarking Dashboard
A commercial analytics dashboard that continuously analyzes outcomes data from clinical registries and EHRs to benchmark therapeutic performance against competitors and standard of care. This provides real-time competitive intelligence for commercial teams and payers, supporting market access strategy and price justification valued at institutional licensing tiers.
Real-World Evidence Biostatistics Platform Dev Click to view more details →
Privacy-Preserving Federated RWE Analysis Network Solution
A secure, distributed biostatistics platform that performs statistical analysis across multiple sites and health systems without centralizing patient data, using differential privacy and federated learning techniques. This unlocks access to previously unavailable patient populations for evidence generation while maintaining HIPAA and GDPR compliance, opening new revenue streams through institutional partnerships.
Real-World Evidence Biostatistics Platform Dev Click to view more details →
Real-World Evidence Statistical Power and Sample Size Calculator
A specialized biostatistics tool that estimates required sample sizes and statistical power for RWE studies accounting for missing data, confounding structures, and observational study design characteristics. This enables researchers to design efficient, adequately powered RWE studies that maximize evidence generation ROI, reducing wasted data collection and analysis efforts by 40%.
Real-World Evidence Biostatistics Platform Dev Click to view more details →
Longitudinal Real-World Evidence Trajectory Modeling Platform
A biostatistics SaaS that models complex patient trajectories and disease progression patterns from longitudinal RWD using mixed-effects models, time-series analysis, and latent class growth analysis. This reveals clinically meaningful patient subgroups and treatment response patterns that support precision medicine claims and patient stratification strategies, enabling premium pricing for targeted use cases.
Real-World Evidence Biostatistics Platform Dev Click to view more details →